SEQUENT.NS Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 13:00):

Stats
Объем за сегодня	473 551
Средний объем	1.52M
Рыночная капитализация	29.56B
EPS	INR0 ( 2024-02-13 )
Дата следующего отчета о доходах	( INR0 ) 2024-05-20
Last Dividend	INR0.500 ( 2021-09-08 )
Next Dividend	INR0 ( N/A )
P/E	-22.83
ATR14	INR0.130 (0.11%)

Объем Корреляция

Длинно: -0.05 (neutral)

Кратко: -0.47 (neutral)

Signal:(52.716) Neutral

Sequent Scientific Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Sequent Scientific Корреляция - Валюта/Сырье

-0.24
( neutral )

-0.45
( neutral )

-0.22
( neutral )

-0.02
( neutral )

-0.31
( neutral )

-0.38
( neutral )

Sequent Scientific Финансовые показатели

Annual	2022
Выручка:	INR14.21B
Валовая прибыль:	INR5.87B (41.32 %)
EPS:	INR-4.88

FY	2022
Выручка:	INR14.21B
Валовая прибыль:	INR5.87B (41.32 %)
EPS:	INR-4.88

FY	2022
Выручка:	INR14.10B
Валовая прибыль:	INR5.66B (40.12 %)
EPS:	INR1.670

FY	2021
Выручка:	INR13.62B
Валовая прибыль:	INR6.25B (45.91 %)
EPS:	INR3.87

Financial Reports:

No articles found.

Sequent Scientific Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sequent Scientific Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.078 - No dividend growth expected in the near future

Information

First Dividend	INR0.200	2017-11-20
Last Dividend	INR0.500	2021-09-08
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	INR0.900	--
Avg. Dividend % Per Year	0.04%	--
Score	0.38	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.078
Div. Directional Score	0.446	--

Next Divdend (Est)
(2025-03-10)

INR0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.38

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0.200	0.30%
2020	INR0	0.00%
2021	INR0.500	0.29%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%
HBSL.NS	Dividend Junior	2023-08-11	Sporadic	12	0.78%
BEPL.NS	Dividend King	2023-07-25	Semi-Annually	20	4.91%
RADICO.NS	Dividend Junior	2023-09-14	Annually	22	0.24%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Knight	2023-08-04	Annually	23	0.57%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0935	1.500	-1.869	-2.80	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.186	1.500	-3.18	-4.77	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-1.024	1.000	-1.490	-1.490	[3 - 30]
operatingCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.93	2.00	8.03	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.374	1.000	7.09	7.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0346	1.000	-2.69	-2.69	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.187

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-22.95	1.000	-2.42	0	[1 - 100]
returnOnEquityTTM	-0.186	2.50	-2.04	-4.77	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.404	1.500	-0.642	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0711	1.000	-0.723	0	[0.1 - 0.5]
Total Score				1.078

Sequent Scientific

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.